Robin Verjans

631 total citations
9 papers, 271 citations indexed

About

Robin Verjans is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robin Verjans has authored 9 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cancer Research and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robin Verjans's work include MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (3 papers) and RNA modifications and cancer (2 papers). Robin Verjans is often cited by papers focused on MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (3 papers) and RNA modifications and cancer (2 papers). Robin Verjans collaborates with scholars based in Netherlands, Belgium and Italy. Robin Verjans's co-authors include Blanche Schroen, Marc van Bilsen, Stéphane Heymans, Rick van Leeuwen, Wouter Verhesen, Arantxa González, T. J. Peters, Marie‐José Goumans, Mitchell Bijnen and Michiel T.H.M. Henkens and has published in prestigious journals such as Scientific Reports, Hypertension and Cardiovascular Research.

In The Last Decade

Robin Verjans

9 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robin Verjans Netherlands	6	191	158	78	35	19	9	271
You Shu China	7	203 1.1×	205 1.3×	92 1.2×	26 0.7×	27 1.4×	14	318
Dena Esfandyari Germany	3	203 1.1×	135 0.9×	117 1.5×	38 1.1×	16 0.8×	3	293
Janet Remke Germany	3	290 1.5×	263 1.7×	109 1.4×	34 1.0×	29 1.5×	4	406
Geraldine E. Malana United States	2	194 1.0×	128 0.8×	103 1.3×	19 0.5×	26 1.4×	3	296
Celina Genschel Germany	3	328 1.7×	266 1.7×	116 1.5×	35 1.0×	17 0.9×	7	450
Steffen Rump Germany	4	303 1.6×	227 1.4×	119 1.5×	29 0.8×	12 0.6×	8	420
Jianqiu Pei China	9	196 1.0×	95 0.6×	103 1.3×	59 1.7×	22 1.2×	20	316
Emily Flam United States	9	229 1.2×	61 0.4×	83 1.1×	18 0.5×	14 0.7×	12	331
Wenying Zheng China	10	173 0.9×	83 0.5×	25 0.3×	26 0.7×	15 0.8×	15	298
Jake Cosme Canada	7	133 0.7×	41 0.3×	62 0.8×	33 0.9×	8 0.4×	9	209

Countries citing papers authored by Robin Verjans

Since Specialization

Citations

This map shows the geographic impact of Robin Verjans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Verjans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Verjans more than expected).

Fields of papers citing papers by Robin Verjans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Verjans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Verjans. The network helps show where Robin Verjans may publish in the future.

Co-authorship network of co-authors of Robin Verjans

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Verjans. A scholar is included among the top collaborators of Robin Verjans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Verjans. Robin Verjans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Verjans, Robin, Annette H. Bruggink, Robby E. Kibbelaar, et al.. (2021). The Dutch National TissueArchive Portal enables efficient, consistent, and transparent procurement of diagnostic tissue samples for scientific use. Cell and Tissue Banking. 22(4). 727–736. 4 indexed citations

Verjans, Robin, Ciska Verbaanderd, Hubert G. M. Leufkens, et al.. (2021). Extension of Indication for Authorised Oncology Products in the European Union: A Joint Effort of Multiple Stakeholders. Frontiers in Medicine. 8. 790782–790782. 3 indexed citations

Verjans, Robin, Marc van Bilsen, & Blanche Schroen. (2020). Reviewing the Limitations of Adult Mammalian Cardiac Regeneration: Noncoding RNAs as Regulators of Cardiomyogenesis. Biomolecules. 10(2). 262–262. 12 indexed citations

Verjans, Robin, Wouter Derks, Kerstin Korn, et al.. (2019). Functional Screening Identifies MicroRNAs as Multi-Cellular Regulators of Heart Failure. Scientific Reports. 9(1). 6055–6055. 29 indexed citations

Bilsen, Marc van, et al.. (2019). tRNAs and tRNA fragments as modulators of cardiac and skeletal muscle function. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(3). 118465–118465. 27 indexed citations

Lumens, Joost, Paolo Carai, Rick van Leeuwen, et al.. (2018). AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism. Molecular Therapy — Nucleic Acids. 14. 424–437. 35 indexed citations

Verjans, Robin, Luca Braga, Paolo Carai, et al.. (2018). P68Cardiomyocyte cell cycle activity and function is under the control of miR-125a. Cardiovascular Research. 114(suppl_1). S18–S18. 1 indexed citations

Verjans, Robin, Marc van Bilsen, & Blanche Schroen. (2017). MiRNA Deregulation in Cardiac Aging and Associated Disorders. International review of cell and molecular biology. 334. 207–263. 27 indexed citations

Verjans, Robin, T. J. Peters, Javier Beaumont, et al.. (2017). MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload–Induced Heart Failure. Hypertension. 71(2). 280–288. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact